Results 281 to 290 of about 993,013 (333)
Some of the next articles are maybe not open access.
Perspectives of immunotherapy in hepatocellular carcinoma (HCC)
Zeitschrift Fur Gastroenterologie, 2016Immunotherapy is considered a new treatment option for many tumor entities, as decades of research into cancer immunotherapy have recently yielded promising results. Indeed, impressive clinical results of checkpoint blockade inhibitors in malignant melanoma and non-small cell lung cancer indicate the therapeutic potential of tumor-specific immune ...
Nathalie Schmidt
exaly +4 more sources
Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)
Journal of Gastrointestinal Cancer, 2017A. Ozakyol
semanticscholar +4 more sources
Recent Insights of Metformin on Hepatocellular Carcinoma (HCC)
Mini-Reviews in Medicinal Chemistry, 2023Abstract: Metformin is an oral hypoglycemic drug, the first option used to treat type 2 diabetes mellitus due to its high efficacy and low cost. Recently, it has drawn attention among researchers due to its new-found antitumor effect. Growing evidence showed that metformin could inhibit cancer progression, especially in hepatocellular carcinoma, and ...
Kaizhen Wang +4 more
openaire +2 more sources
Multimodal Treatment of Hepatocellular Carcinoma (HCC)
Oncology Research and Treatment, 2004Screening of patients at risk for hepatocellular carcinomas (HCC) and preventive virustatic therapy are the first steps in a multimodal treatment concept, because delayed detection leads to a poor prognosis with median survival of
J W, Sturm, M, Keese
openaire +2 more sources
Epidemiology of hepatocellular carcinoma (HCC) in hemophilia
Critical Reviews in Oncology/Hematology, 2016Hepatocellular carcinoma (HCC) is an important cause of increasing mortality in elderly hemophilia population. Majority of the patients treated with virus non-inactivated factor concentrates prepared from large plasma pools prior to 1985 have been found to be infected with hepatitis C virus (HCV), a major risk factor for HCC.
Shrimati, Shetty +2 more
openaire +2 more sources
Biomarkers for Hepatocellular Carcinoma (HCC): An Update
2015The past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention.
Dave, Li, Shinji, Satomura
openaire +2 more sources
Management of Hepatocellular Carcinoma (HCC)
Current Surgery Reports, 2016Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related death. Historically, HCC has been a problem mostly faced by patients from Asian countries due to the high prevalence of hepatitis B (HBV).
Daniel P. Milgrom +2 more
openaire +1 more source
Hepatology Research, 2019
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development ...
N. Kokudo +20 more
semanticscholar +1 more source
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development ...
N. Kokudo +20 more
semanticscholar +1 more source